Ke Chen
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Epigenetics and DNA Methylation 7
- Cancer-related gene regulation 6
-
- Ferroptosis and cancer prognosis 12
- Prostate Cancer Treatment and Research 10
- Renal cell carcinoma treatment 9
- Co-authors
- Junyi Hu (13 shared papers)Lilong Liu (15 shared papers)Yaxin Hou (10 shared papers)Lijie Zhou (9 shared papers)Xiaoping Zhang (32 shared papers)Ming Xiong (4 shared papers)Hailong Ruan (24 shared papers)Zhaohui Chen (4 shared papers)
- Journals
- Journal of Cancer (6 papers)Cancer Research (4 papers)International Journal of Oncology (4 papers)Cellular Physiology and Biochemistry (3 papers)Clinical and Translational Medicine (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ke Chen
140 papers receiving 3.6k citations
Ke Chen's Hit Papers
Peers
Comparison fields: 5 of 130
- Cancer Research 829
- Oncology 625
- Molecular Biology 1.6k
- Immunology 430
- Pulmonary and Respiratory Medicine 595
Countries citing papers authored by Ke Chen
This map shows the geographic impact of Ke Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Chen more than expected).
Fields of papers citing papers by Ke Chen
This network shows the impact of papers produced by Ke Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Chen. The network helps show where Ke Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma Hit paper breakdown → | 2020 | 434 |
| 2 | 2020 | 130 | |
| 3 | 2020 | 107 | |
| 4 | 2020 | 89 | |
| 5 | 2020 | 85 | |
| 6 | 2017 | 82 | |
| 7 | T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome. | 2007 | 81 |
| 8 | 2015 | 77 | |
| 9 | 2020 | 73 | |
| 10 | 2018 | 69 | |
| 11 | 2017 | 67 | |
| 12 | 2013 | 66 | |
| 13 | 2010 | 64 | |
| 14 | 2018 | 64 | |
| 15 | 2019 | 62 | |
| 16 | 2019 | 55 | |
| 17 | 2020 | 51 | |
| 18 | 2022 | 47 | |
| 19 | 2022 | 47 | |
| 20 | 2019 | 45 |
About Ke Chen
Ke Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Cancer Research, having authored 148 papers that have together received 3.6k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Prostate Cancer Treatment and Research (10 papers), Cancer, Lipids, and Metabolism (10 papers), Renal cell carcinoma treatment (9 papers), Epigenetics and DNA Methylation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer-related gene regulation (6 papers). The work is most often cited by research in Cancer Research (829 citations), Oncology (625 citations), Molecular Biology (1.6k citations), Immunology (430 citations) and Pulmonary and Respiratory Medicine (595 citations). Ke Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Junyi Hu, Lilong Liu, Yaxin Hou, Lijie Zhou, Xiaoping Zhang, Ming Xiong, Hailong Ruan, Zhaohui Chen, Hongmei Yang and Yu Yang. Their work appears in journals such as Journal of Cancer, Cancer Research, International Journal of Oncology, Cellular Physiology and Biochemistry and Clinical and Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.